Position in INCY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,105,600
+$253,062 QoQ
Shares Held
9,753
+7.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#400
of 854 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthfront Advisers LLC holds $35,327,037 across 19 Biotechnology names. INCY ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,608 | $20,667,941 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,006 | $4,368,521 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,554 | $2,876,040 | |
| 4 | INSM |
INSMED Inc
|
17,511 | $1,867,022 | |
| 5 | INCY |
Incyte Corp
This page
|
9,753 | $1,105,600 | |
| 6 | MRNA |
Moderna, Inc.
|
15,621 | $1,093,938 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
39,822 | $587,772 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
8,602 | $469,153 |
All Filings in INCY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,105,600 | 9,753 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $852,538 | 9,058 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $848,533 | 8,591 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $694,339 | 8,187 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $501,624 | 7,366 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $435,657 | 7,195 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,613,194 | 37,834 | Shares | Sole | 2025-04-01 | |
| 2024-09-30 | $2,106,210 | 31,864 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $356,869 | 5,887 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,465,895 | 25,731 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,178,492 | 50,621 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,181,684 | 37,765 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,158,129 | 50,733 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,507,190 | 62,366 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,583,573 | 32,166 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,331,133 | 34,981 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,055,748 | 27,060 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,427,971 | 17,980 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $238,087 | 2,830 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $234,463 | 2,885 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $212,144 | 2,439 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $497,339 | 5,542 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $919,718 | 8,846 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||